Jasper Bos is a General Partner at Forbion and has served on various boards, including CellCentric and CatalYm GmbH. Previously, they held the position of Chief Executive Officer at Forbion European Acquisition Corporation from 2021 to 2023 and Chairman of the Board at Calypso Biotech SA from 2013 to 2019. With a background in healthcare investment, Jasper was also involved with Merck Serono in various senior roles from 2009 to 2011. They earned both an MSc and a PhD in pharmacoeconomics from the University of Groningen, where they were a research fellow from 1999 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices